Joseph L Goldstein Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Joseph L Goldstein is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 6,382 shares of REGN, which is worth approximately $7.36 Million. The most recent transaction as insider was on Jan 23, 2024, when has been sold 2,707 shares (Common Stock) at a price of $950.0 per share, resulting in proceeds of $2,571,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.38K

0% 3M change

2.16% 12M change

Total Value Held $7.36 Million

JOSEPH L GOLDSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 23 2024	SELL Open market or private sale	$2,571,650 $950.0 p/Share	2,707 Reduced 29.78%	6,382 Common Stock
Jan 23 2024	BUY Exercise of conversion of derivative security	$1,693,499 $625.6 p/Share	2,707 Added 22.95%	9,089 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	135 Added 2.07%	6,382 Common Stock
Feb 06 2023	SELL Open market or private sale	$2,890,400 $800.0 p/Share	3,613 Reduced 36.64%	6,247 Common Stock
Feb 06 2023	BUY Exercise of conversion of derivative security	$1,743,922 $482.68 p/Share	3,613 Added 26.82%	9,860 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	165 Added 2.57%	6,247 Common Stock
Mar 30 2022	SELL Open market or private sale	$1,701,700 $700.0 p/Share	2,431 Reduced 28.56%	6,082 Common Stock
Mar 30 2022	BUY Exercise of conversion of derivative security	$909,486 $374.12 p/Share	2,431 Added 22.21%	8,513 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	191 Added 3.04%	6,082 Common Stock
Sep 10 2021	SELL Open market or private sale	$1,611,350 $650.0 p/Share	2,479 Reduced 29.62%	5,891 Common Stock
Sep 10 2021	BUY Exercise of conversion of derivative security	$944,375 $380.95 p/Share	2,479 Added 22.85%	8,370 Common Stock
Jun 07 2021	SELL Open market or private sale	$1,013,250 $525.0 p/Share	1,930 Reduced 24.68%	5,891 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$722,052 $374.12 p/Share	1,930 Added 19.79%	7,821 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	248 Added 4.04%	5,891 Common Stock
Oct 05 2020	SELL Open market or private sale	$5,527,200 $600.0 p/Share	9,212 Reduced 62.01%	5,643 Common Stock
Oct 05 2020	BUY Exercise of conversion of derivative security	$4,790,332 $520.01 p/Share	9,212 Added 38.28%	14,855 Common Stock

JLG

Joseph L Goldstein

Director

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account